Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans.

[1]  J. Gromada,et al.  C16:0 Sulfatide Inhibits Insulin Secretion in Rat β-Cells by Reducing the Sensitivity of KATP Channels to ATP Inhibition , 2006, Diabetes.

[2]  M. Carrier,et al.  In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose‐stimulated insulin secretion in Zucker fatty (fa/fa) rats , 2005, Diabetes/metabolism research and reviews.

[3]  Hiroko Suzuki,et al.  Lipid Compositions of Human Gastric Fluid and Epithelium: The Role of Sulfated Lipids in Gastric Cytoprotection , 2005, Journal of clinical gastroenterology.

[4]  I. Maričić,et al.  Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide , 2004, The Journal of experimental medicine.

[5]  K. Bendtzen,et al.  Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. , 2004, Immunology letters.

[6]  J. Månsson,et al.  Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  R. Hershberg,et al.  Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. , 2003, Gastroenterology.

[8]  J. Gromada,et al.  Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells. , 2002, Diabetes.

[9]  G. De Libero,et al.  Presentation of the Same Glycolipid by Different CD1 Molecules , 2002, The Journal of experimental medicine.

[10]  F. Lépine,et al.  LC-MS analysis of pig intestine sulfatides: interaction with Escherichia coli STb enterotoxin and characterization of molecular species present. , 2002, FEMS microbiology letters.

[11]  H. Mortensen,et al.  Patients with Insulin-dependent Diabetes but not those with Non-insulin-dependent Diabetes have Anti-sulfatide Antibodies as Determined with a New ELISA Assay , 2002, Autoimmunity.

[12]  J. Whittingham,et al.  Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. , 2001, Glycobiology.

[13]  J. Raulston,et al.  Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members. , 2001, Biochemistry.

[14]  K. Hanspers,et al.  Treatment with Sulfatide or its Precursor, Galactosylceramide, Prevents Diabetes in NOD Mice , 2001, Autoimmunity.

[15]  M. Miyasaka,et al.  Sulfatide binding and activation of leukocytes through an L‐selectin‐independent pathway , 2000, Journal of leukocyte biology.

[16]  A. Nilsson,et al.  Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract. , 1999, Chemistry and physics of lipids.

[17]  B. Roep,et al.  Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cells , 1999, Diabetologia.

[18]  K. Bendtzen,et al.  In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide , 1999, FEBS letters.

[19]  Y. Hannun,et al.  The role of ceramide in cell signaling. , 1998, Biochimica et biophysica acta.

[20]  J. Turk,et al.  Electrospray ionization tandem mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species expressed in brain and in pancreatic islets. , 1998, Biochimica et biophysica acta.

[21]  P. Courtoy,et al.  Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue , 1998, FEBS letters.

[22]  I. Ishizuka.  Chemistry and functional distribution of sulfoglycolipids. , 1997, Progress in lipid research.

[23]  C. Lingwood.  Aglycone modulation of glycolipid receptor function , 1996, Glycoconjugate Journal.

[24]  A. K. Hansen,et al.  Neonatal treatment of BB rats with sulphatide delays development of diabetes but does not change incidence , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[25]  A. Merrill,et al.  Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. , 1994, The Journal of nutrition.

[26]  T. Horn,et al.  Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus , 1993, The Lancet.

[27]  K. Sugano,et al.  Systematic analysis of glycosphingolipids in the human gastrointestinal tract: Enrichment of sulfatides with hydroxylated longer-chain fatty acids in the gastric and duodenal mucosa , 1993, Lipids.

[28]  K. Buschard,et al.  Sulphatide antigen in islets of Langerhans and in diabetic glomeruli, and anti‐sulphatide antibodies in Type 1 diabetes mellitus , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[29]  S. Balk,et al.  Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. , 1991, Journal of immunology.

[30]  P. Davidsson,et al.  Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[31]  T. Flotte,et al.  Expression of murine CD1 on gastrointestinal epithelium. , 1990, Science.

[32]  M. Iwamori,et al.  Glycosphingolipid Composition of the Gastric Mucosa: A Role of Sulfatides in Gastrointestinal Mucosal Defense? , 1990, Journal of clinical gastroenterology.

[33]  J. Månsson,et al.  Lysosulfatide (Galactosylsphingosine‐3‐O‐Sulfate) from Metachromatic Leukodystrophy and Normal Human Brain , 1989, Journal of neurochemistry.

[34]  Takaku Fumimaro,et al.  Region-specific distribution of glycosphingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid. , 1988 .

[35]  L. Mattsson,et al.  Characterization of the binding epitope of a monoclonal antibody to sulphatide. , 1988, The Biochemical journal.

[36]  S. Hakomori,et al.  Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. , 1983, Cancer research.

[37]  M. Breimer,et al.  The preparative separation of sialic acid-containing lipids from sulphate group-containing glycolipids from small intestine of different animals. Analysis by thin-layer chromatography and detection of novel species. , 1983, Journal of biochemistry.

[38]  S. Hakomori,et al.  Possible role of ceramide in defining structure and function of membrane glycolipids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Svennerholm,et al.  A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.

[40]  J. Månsson,et al.  The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[41]  G. Schwarzmann,et al.  A simple and novel method for tritium labeling of gangliosides and other sphingolipids. , 1978, Biochimica et biophysica acta.

[42]  A. Nilsson,et al.  Metabolism of cerebroside in the intestinal tract of the rat. , 1969, Biochimica et biophysica acta.

[43]  A. Nilsson,et al.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. , 1969, Biochimica et biophysica acta.

[44]  A. Nilsson,et al.  Metabolism of sphingomyelin in the intestinal tract of the rat. , 1968, Biochimica et biophysica acta.

[45]  J. Månsson,et al.  The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. , 2000, Glycobiology.

[46]  K. Bendtzen,et al.  Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans. , 1990, Autoimmunity.